Sierra Oncology
$17.589876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$17.58
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.56 (-3.09%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell SRRA and other stocks, options, and ETFs commission-free!
About SRRA
Sierra Oncology, Inc. Common Stock, also called Sierra Oncology, is a clinical stage drug development company of therapeutics for the treatment of cancer.
CEO
Stephen George Dilly
Employees
69
Headquarters
Vancouver, British Columbia
Founded
2003
Market Cap
212.32M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
14.48K
High Today
$18.99
Low Today
$17.26
Open Price
$18.00
Volume
10.21K
52 Week High
$20.43
52 Week Low
$9.32
SRRA Earnings
-$3.16
-$2.11
-$1.05
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, Pre-Market